Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 6Interventional 3

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 3Breast 2Genitourinary 1

Conditions

Pancreatic Neoplasms 2Ovarian Neoplasms 1Esophageal Neoplasms 1

Interventions

Oxaliplatin 1409Fluorouracil 1298Capecitabine 1085Gemcitabine 1042Leucovorin 928Irinotecan 815Bevacizumab 803Cisplatin 666Radiotherapy 535Cetuximab 469pembrolizumab 428Paclitaxel 389Nivolumab 336130-nm albumin-bound paclitaxel 322Drug Therapy 314Docetaxel 286S 1 (combination) 273Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 209Surgical Procedures, Operative 203tislelizumab 202Radiosurgery 202lenvatinib 201apatinib 198Carboplatin 186Magnetic Resonance Spectroscopy 181regorafenib 180

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Histocompatibility Testing × Gastrointestinal × Clear all
NCT06144762 2025-02-12

PANC-O-MICS

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting
150 enrolled
GastrointestinalGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms

NCT01434550 2017-02-23

Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT00319735 2016-04-28

Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas

Hoosier Cancer Research Network

Phase 2 Completed
41 enrolled 18 charts
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡